- Home
- WERN vs IDYA Comparison
WERN vs IDYA Comparison
Compare WERN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WERN | IDYA |
|---|---|---|
| Founded | 1956 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WERN | IDYA |
|---|---|---|
| Price | $42.20 | $36.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | $33.79 | ★ $52.86 |
| AVG Volume (30 Days) | 879.2K | ★ 1.3M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ 61.90 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,974,396,000.00 | $218,710,000.00 |
| Revenue This Year | $22.24 | N/A |
| Revenue Next Year | $6.33 | $201.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3024.43 |
| 52 Week Low | $23.06 | $20.50 |
| 52 Week High | $45.27 | $39.28 |
Technical Indicators
Market Signals| Indicator | WERN | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 57.33 | 73.27 |
| Support Level | $39.68 | $32.85 |
| Resistance Level | $45.27 | $38.15 |
| Average True Range (ATR) | 1.52 | 1.98 |
| MACD | -0.47 | 0.86 |
| Stochastic Oscillator | 44.72 | 85.39 |
Price Performance
Historical ComparisonAbout WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.